What is the main business of Alab-Med?

The main business activity of Alab-Med focuses on other human health activities not elsewhere classified.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 27, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Stępińska 22/30, 00-739 Warszawa.

Who is on the management board?

The management board consists of: Maciej Władysław Hipsz (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

The company reported a revenue of $1,770,256 in 2024, which is an increase of 418.6% compared to 2023.

Is the company profitable?

Yes, in 2024 the company achieved a net profit of $1,105,135.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $268,312 in 2024, representing 83% of all operating expenses.

Alab-Medsp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2015-10-27

Share capital

50 000,00 PLN

Activity description

Alab-Med is a key distributor of specialized laboratory equipment for Life Science and Medical Diagnostics laboratories. The company offers high-specialty laboratory equipment, advanced technologies, software, authorized service, and high-quality reagents and consumables from over 30 manufacturers, including exclusive products like CleanAir by Baker laminar flow cabinets and Thermo Scientific CO₂/O₂ incubators.

Registered address

ul. Stępińska 22/30, 00-739 Warszawa, Poland

Website

alab.com.pl

Phone

Social media

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 1.77mMedianUSD 92.16kAverageUSD 1.47m

Net profit

This companyUSD 1.11mMedianUSD 2.46kAverageUSD 170.36k

Operating costs

This companyUSD 322.13kMedianUSD 85.23kAverageUSD 1.19m

Assets

This companyUSD 2.12mMedianUSD 40.76kAverageUSD 1.02m

Industry

Bank accounts

Registered as a VAT taxpayer on 2015-11-13. Active

mBank
10 1140 2062 0000 2711 8200 1001

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Maciej Władysław Hipsz — President of the Management Board

Tomasz Mariusz Łaszkiewicz — Attorney-in-fact

Manner of representation

The company is represented by each member of the management board acting independently.

Ownership

Owner	Shares	Share value	Stake
Bogusław Tadeusz Gnatowski (74)	500	$6,753.11	50%
Ewa Małkowska (61)	500	$6,753.11	50%

Beneficial owners

Person	Rights
Bogusław Tadeusz Gnatowski (74)	Shareholder of a limited liability company, 25000.0 PLN
Ewa Małkowska (61)	Shareholder of a limited liability company, 25000.0 PLN

Competitors

Name	Revenue	Website
Zakład Patomorfologii Alfamedsp. z o.o.	$4,020,860.77	alfamed.biz
Masdiagsp. z o.o.	$1,691,863.39	masdiag.pl
Laboratorium Analiz Lekarskich Laborsp. z o.o.	$691,893.69	labor-ostrzeszow.pl
MED Systemssp. z o.o.	$380,011.77	med-systems.pl

FAQ

Last updated: 2026-06-25